List of ArisGlobal LifeSphere NavaX Customers
Waltham, 2451, MA,
United States
Since 2010, our global team of researchers has been studying ArisGlobal LifeSphere NavaX customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased ArisGlobal LifeSphere NavaX for Cognitive Computing from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using ArisGlobal LifeSphere NavaX for Cognitive Computing include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Boehringer Ingelheim, a Germany based Life Sciences organisation with 54500 employees and revenues of $28.94 billion, Nippon Shinyaku Japan, a Japan based Life Sciences organisation with 2243 employees and revenues of $1.03 billion, Boehringer Ingelheim Veterinary Research Center & Co., a Germany based Life Sciences organisation with 13 employees and revenues of $3.0 million and many others.
Contact us if you need a completed and verified list of companies using ArisGlobal LifeSphere NavaX, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The ArisGlobal LifeSphere NavaX customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | ArisGlobal | ArisGlobal LifeSphere NavaX | Cognitive Computing | 2017 | n/a |
In 2017, AstraZeneca signed a multi year agreement to adopt ArisGlobal LifeSphere Signal & Risk Management to modernize global signal surveillance and risk management across its safety organization. The engagement is described as a multi year commitment that positions the ArisGlobal suite as the primary platform for pharmacovigilance signal workflows across AstraZeneca's safety organization.
AstraZeneca's deployment centers on ArisGlobal LifeSphere NavaX as the cognitive engine for LifeSphere, inferred from ArisGlobal positioning NavaX as the cognitive layer for LifeSphere and the stated move to modernize signal and risk management. Implementation work is aligned to Signal & Risk Management capabilities, with analyst aligned expectations of cognitive signal detection, consolidated signal assessment workflows, and structured risk management processes typical of the category.
Operational coverage is scoped to AstraZeneca's global safety organization and pharmacovigilance functions, with the rollout planned over multiple years to phase adoption across safety teams and regional surveillance units. Governance activities are described at the program level, focusing on standardizing signal review workflows, configuring safety case and aggregate assessment logic, and embedding NavaX enabled cognitive features into ongoing signal triage and assessment practices.
|
 |
Boehringer Ingelheim | Life Sciences | 54500 | $28.9B | Germany | ArisGlobal | ArisGlobal LifeSphere NavaX | Cognitive Computing | 2025 | n/a |
In 2025, Boehringer Ingelheim implemented ArisGlobal LifeSphere NavaX to automate safety case intake across its global pharmacovigilance operations, Apps Category: . The deployment centralized case intake workflows, introduced automated data extraction and structured intake forms to support initial triage and validation, and was configured to reduce manual touchpoints in the intake pipeline.
ArisGlobal LifeSphere NavaX was tuned to perform extraction and normalization steps at the point of intake, reporting up to 90% data extraction accuracy within weeks and reducing manual effort as part of the rollout. The implementation targeted safety and pharmacovigilance case intake at a global scale, impacting safety teams and case management functions, and included governance changes to standardize intake workflows and sustain improved intake data quality.
|
 |
Boehringer Ingelheim Veterinary Research Center & Co. | Life Sciences | 13 | $3M | Germany | ArisGlobal | ArisGlobal LifeSphere NavaX | Cognitive Computing | 2025 | n/a |
In 2025, Boehringer Ingelheim Veterinary Research Center & Co. implemented ArisGlobal LifeSphere NavaX to modernize pharmacovigilance case intake. Category:
The implementation centralized NavaX-powered Advanced Intake to process individual case safety reports, using ArisGlobal LifeSphere NavaX as the core cognitive engine. Configuration emphasized GenAI-driven Dynamic Data Extraction for ICSR form parsing, with explicit support for automated data capture workflows and embedded quality control checkpoints to preserve validation and review gates.
Deployment targeted global safety operations and pharmacovigilance teams, with operational coverage focused on case intake, triage and routing, and enabling downstream medical review and benefit-risk analysis. The solution architecture positions NavaX within LifeSphere Unify as the AI layer that orchestrates Advanced Intake, allowing case data to be extracted, normalized and handed off to safety workflows and reviewers.
Governance centered on process standardization for intake and quality control, reducing manual data entry while retaining human review steps for compliance. Outcomes reported within weeks include up to 90 percent average data extraction accuracy and measurable reduction in manual effort, enabling safety teams to concentrate on higher-value activities such as medical review and benefit-risk assessment.
|
 |
|
Life Sciences | 2243 | $1.0B | Japan | ArisGlobal | ArisGlobal LifeSphere NavaX | Cognitive Computing | 2025 | n/a |
|
Buyer Intent: Companies Evaluating ArisGlobal LifeSphere NavaX
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||